Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ravi Doddapaneni"'
Publikováno v:
Data in Brief, Vol 49, Iss , Pp 109330- (2023)
Adenoid cystic carcinoma of the lacrimal gland (LGACC) is a slow-growing but aggressive orbital malignancy. Due to the rarity of LGACC, it is poorly understood, which makes diagnosing, treating, and monitoring disease progression difficult. The aim i
Externí odkaz:
https://doaj.org/article/67c9bede1fc247518bac2023d221e70a
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278711 (2022)
Breast cancer is heterogenous in development and cell population with prognoses being highly dependent on numerous factors from driving mutations, biomarker expression and variation in extracellular environment, all affecting response to therapies. R
Externí odkaz:
https://doaj.org/article/23c6b1dfa828407f8f9b5f3a9d45fb10
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e89919 (2014)
The poor bioavailability of Berberine (BBR) and Betulinic acid (BA) limits the development of these promising anticancer agents for clinical use. In the current study, BBR and BA in spray dried (SD) mucoadhesive microparticle formulations were prepar
Externí odkaz:
https://doaj.org/article/b5e2069f0c504f63a21ebf7fd2c24b7d
Autor:
Cedar H A Boakye, Ravi Doddapaneni, Punit P Shah, Apurva R Patel, Chandraiah Godugu, Stephen Safe, Santosh K Katiyar, Mandip Singh
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e69519 (2013)
The objective of this study was to demonstrate the anti-skin cancer and chemopreventive potential of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl methane) (DIM-D) using an in vitro model.In vitro cell cytotoxicity and viability assays were carried out in A4
Externí odkaz:
https://doaj.org/article/08a1e4154fb443fba09cea3a95bb3950
Autor:
Mandip Singh, Nusrat Chowdhury, Imran Vhora, Shallu Kutlehria, Gautam Behl, Ravi Doddapaneni, Ketan Patel, Arvind Bagde
Publikováno v:
AAPS PharmSciTech. 19:792-802
Triple-negative breast cancer (TNBC) is the leading cancer in women. Chemotherapeutic agents used for TNBC are mainly associated with dose-dependent toxicities and development of resistance. Hence, novel strategies to overcome resistance and to offer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd9f4d8d95cfa74f092eeabed54ddde7
https://doi.org/10.1208/s12249-017-0885-z
https://doi.org/10.1208/s12249-017-0885-z
Publikováno v:
Pharmaceutical Research. 34:2371-2384
Non-small cell lung cancer is the leading cause of cancer related deaths globally. Considering the side effects and diminishing chemosensitivity to chemotherapy, novel treatment approaches are sought. Hence, we aim to develop a liposomal co-delivery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2e10d0adc7867dff96aa68bf118e72
https://doi.org/10.1007/s11095-017-2244-x
https://doi.org/10.1007/s11095-017-2244-x
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 153:208-219
Triple negative breast cancer (TNBC), owing to its aggressive behavior and toxicity associated with available chemotherapy; currently no suitable therapy is available. Honokiol (HNK) is a promising anticancer drug but has poor bioavailability. In the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303d5bf8dcadb238ec999a6adb2f6c52
https://doi.org/10.1016/j.colsurfb.2017.01.038
https://doi.org/10.1016/j.colsurfb.2017.01.038
Autor:
Mandip Singh, Ketan Patel, Ravi Doddapaneni, Srujan Marepally, Arvind Bagde, Cedar H. A. Boakye
Publikováno v:
Journal of Controlled Release. 246:120-132
In this study, we demonstrate for the first time the concurrent transdermal delivery of erlotinib and IL36α siRNA as a potential dual therapy for psoriasis. The objectives were to develop and evaluate lipid nanocarriers (CYnLIP) using a novel pyrrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa51a22d932788016678ec416e039286
https://doi.org/10.1016/j.jconrel.2016.05.017
https://doi.org/10.1016/j.jconrel.2016.05.017
Publikováno v:
AAPS PharmSciTech. 20
Lung cancer patients develop acquired resistance to tyrosine kinase inhibitors including erlotinib (ERL) after few months of primary treatment. Evidently, new chemotherapy strategies to delay or overcome the resistance are urgently needed to improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f336baa84c77f6276abf366af46f993
https://doi.org/10.1208/s12249-019-1332-0
https://doi.org/10.1208/s12249-019-1332-0
Autor:
Anthony J. Griswold, Stefan Kurtenbach, Andrew J. Rong, Daniel Pelaez, David T. Tse, Ryan A. Gallo, Michelle Zhang, John Y. Lee, Sander R. Dubovy, Ravi Doddapaneni
Publikováno v:
Translational Vision Science & Technology
Purpose Sebaceous carcinoma (SC) is a malignant eyelid tumor of the ocular adnexa that is primarily treated via surgical excision. Few therapies exist in advanced cases, and medical therapy is limited because of our incomplete understanding of SC bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d912ead9838865ab07f8ecc1d24311
https://doi.org/10.1167/tvst.10.6.34
https://doi.org/10.1167/tvst.10.6.34